Bonvicini, Cristian http://orcid.org/0000-0003-1577-2823
Cortese, Samuele http://orcid.org/0000-0001-5877-8075
Maj, Carlo http://orcid.org/0000-0002-9559-1725
Baune, Bernhard T. http://orcid.org/0000-0001-6548-426X
Faraone, Stephen V. http://orcid.org/0000-0002-9217-3982
Scassellati, Catia http://orcid.org/0000-0003-2077-0830
Funding for this research was provided by:
Ministero della Salute
EC | Horizon 2020 Framework Programme (667302)
Article History
Received: 20 February 2019
Revised: 10 December 2019
Accepted: 20 December 2019
First Online: 19 February 2020
Conflict of interest
: Cristian Bonvicini Ph.D., Catia Scassellati, PhD, Carlo Maj and Bernhard T. Baune declare that they have no conflict of interest. Prof. Steve Faraone, in the past year, received income, potential income, travel expenses continuing education support and/or research support from Tris, Otsuka, Arbor, Ironshore, Shire, Akili Interactive Labs, VAYA, Ironshore, Sunovion, Supernus and Genomind. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. He also receives royalties from books published by Guilford Press: Straight Talk about Your Child’s Mental Health, Oxford University Press: Schizophrenia: The Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. He is the principal investigator of ExternalRef removed. Prof. Samuele Cortese: Dr Cortese reports receiving reimbursement for travel and accommodation expenses from the Association for Child and Adolescent Central Health (ACAMH), a non-profit organization, in relation to lectures that he delivered for ACAMH and by Healthcare convention for educational activity on ADHD.